Using live imaging and cellular barcoding, researchers in the Stem Cell Program at Boston Children's Hospital have glimpsed how new stem cells—in this case, blood stem cells—are vetted for quality soon after they're born. The study, which may have implications for cancer and regenerative medicine, was published September 22 in the journal Science.